Htm Cream is a topical formulation combining Hydroquinone (2% w/w), Mometasone Furoate (0.1% w/w), and Tretinoin (0.025% w/w) designed for the treatment of hyperpigmentation disorders and inflammatory dermatoses. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and effectively lightening hyperpigmented lesions such as melasma, freckles, and post-inflammatory hyperpigmentation. Mometasone Furoate, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, helping to reduce erythema, swelling, and irritation associated with inflammatory skin conditions. Tretinoin, a retinoid derivative of vitamin A, promotes epidermal cell turnover and enhances penetration of hydroquinone, facilitating the removal of pigmented keratinocytes and improving overall skin texture. The combination therapy offers synergistic benefits in managing pigmentary disorders while controlling inflammation and accelerating skin renewal. Htm Cream should be applied topically as directed by a healthcare professional, typically once daily to affected areas, with caution to avoid prolonged use due to potential side effects such as skin irritation, dryness, and steroid-induced atrophy. It is contraindicated in patients with hypersensitivity to any component and should be used under medical supervision, especially in pregnant or lactating women.